Peer-reviewedCC BY-NC-ND 4.0Scientific Reports
Fear of progression as a mediator between symptom burden and social alienation in lung cancer patients undergoing chemotherapy
Related
- Prognostic value of the neutrophil-to-lymphocyte ratio in patients with colorectal cancer undergoing chemotherapy: a systematic review and meta-analysis
- Effect of Danggui Buxue Medicinal Diet on cancer-related fatigue in anemic colon cancer patients undergoing chemotherapy : A randomized controlled trial (CONSORT-compliant)
- Pretreatment Body Composition and Its Association with Pathologic Complete Response and Survival in Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy: A Retrospective Cohort Study
- Designing and optimizing an intelligent health informatics management platform for patients undergoing chemotherapy for breast cancer: from needs assessment to pilot testing
- Electroacupuncture Combined with Cognitive Behavioral Therapy for Insomnia Alleviates Insomnia-Anxiety Comorbidity in Gynecological Cancer Patients Undergoing Chemotherapy: A Randomized Controlled Trial.
BibTeX
@article{xu2026fear,
title = {{Fear of progression as a mediator between symptom burden and social alienation in lung cancer patients undergoing chemotherapy}},
author = {Fan Xu and Shaoju Xie and Qiao Li and Ping Zhang and Jiquan Zhang},
journal = {Scientific Reports},
year = {2026},
month = oct,
doi = {10.1038/s41598-026-73158-7},
url = {https://www.nature.com/articles/s41598-026-73158-7},
note = {CC BY-NC-ND 4.0},
}
RIS
TY - JOUR
TI - Fear of progression as a mediator between symptom burden and social alienation in lung cancer patients undergoing chemotherapy
AU - Fan Xu
AU - Shaoju Xie
AU - Qiao Li
AU - Ping Zhang
AU - Jiquan Zhang
PY - 2026
DA - 2026/10/01
JO - Scientific Reports
DO - 10.1038/s41598-026-73158-7
UR - https://www.nature.com/articles/s41598-026-73158-7
SN - 2045-2322
ER -